Labcorp Holdings (LH) Current Deferred Revenue (2015 - 2026)

Labcorp Holdings has reported Current Deferred Revenue for 12 years, with the latest figure at $405.2 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 4.35% year-over-year to $405.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $405.2 million (up 4.35% YoY) and the FY2025 annual result came in at $439.1 million, up 11.96% from the prior year.
• Current Deferred Revenue eased to $405.2 million in Q1 2026 per LH's latest filing, from $439.1 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $586.7 million in Q1 2023 and troughed at $310.6 million in Q4 2022.
• A 5-year average of $426.1 million and a median of $398.0 million in 2025 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue plunged 44.39% in 2022, then surged 35.77% in 2023.
• Over 5 years, Current Deferred Revenue stood at $310.6 million in 2022, then soared by 35.77% to $421.7 million in 2023, then retreated by 7.0% to $392.2 million in 2024, then grew by 11.96% to $439.1 million in 2025, then retreated by 7.72% to $405.2 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $405.2 million, $439.1 million, and $391.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.